AU2002213048A1 - Phosphate transport inhibitors - Google Patents
Phosphate transport inhibitorsInfo
- Publication number
- AU2002213048A1 AU2002213048A1 AU2002213048A AU1304802A AU2002213048A1 AU 2002213048 A1 AU2002213048 A1 AU 2002213048A1 AU 2002213048 A AU2002213048 A AU 2002213048A AU 1304802 A AU1304802 A AU 1304802A AU 2002213048 A1 AU2002213048 A1 AU 2002213048A1
- Authority
- AU
- Australia
- Prior art keywords
- transport inhibitors
- phosphate transport
- phosphate
- inhibitors
- transport
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23806800P | 2000-10-05 | 2000-10-05 | |
| US60238068 | 2000-10-05 | ||
| US60/238,068 | 2000-10-05 | ||
| PCT/US2001/031318 WO2002028353A2 (en) | 2000-10-05 | 2001-10-05 | Phosphate transport inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002213048A1 true AU2002213048A1 (en) | 2002-04-15 |
Family
ID=22896359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002213048A Abandoned AU2002213048A1 (en) | 2000-10-05 | 2001-10-05 | Phosphate transport inhibitors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002213048A1 (en) |
| WO (1) | WO2002028353A2 (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19830431A1 (en) * | 1998-07-08 | 2000-01-13 | Hoechst Marion Roussel De Gmbh | Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
| SE0001899D0 (en) | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
| MXPA03011452A (en) | 2001-06-11 | 2005-03-07 | Virochem Pharma Inc | Thiophene derivatives as antiviral agents for flavivirus infection. |
| GB2378179A (en) * | 2001-08-03 | 2003-02-05 | Pantherix Ltd | Aromatic sulfonamides and their use in treating bacterial diseases |
| EA200400707A1 (en) | 2001-11-22 | 2004-10-28 | Биовитрум Аб | INHIBITORS 11-BETA-HYDROXYSTEROID DEGYDROGENASE TYPE 1 |
| KR20050044517A (en) * | 2001-11-22 | 2005-05-12 | 바이오비트럼 에이비 | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| US7119120B2 (en) * | 2001-12-26 | 2006-10-10 | Genzyme Corporation | Phosphate transport inhibitors |
| US7119112B2 (en) * | 2002-02-28 | 2006-10-10 | Icagen, Inc. | Sulfonamides as potassium channel blockers |
| PT1569929E (en) | 2002-12-10 | 2010-06-18 | Virochem Pharma Inc | Compounds and methods for the treatment or prevention of flavivirus infections |
| US7288538B2 (en) | 2003-02-20 | 2007-10-30 | Encysive Pharmaceuticals, Inc. | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists |
| AU2004212985B2 (en) * | 2003-02-20 | 2010-10-14 | Encysive Pharmaceuticals Inc. | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists |
| EP1879879B1 (en) | 2005-05-13 | 2013-03-27 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| GB0526255D0 (en) | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
| US20100056791A1 (en) | 2006-09-01 | 2010-03-04 | Yasushi Kohno | Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| EP2207772A1 (en) * | 2007-10-05 | 2010-07-21 | Encysive Pharmaceuticals, Inc. | Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| KR101766619B1 (en) | 2008-12-31 | 2017-08-08 | 알데릭스, 인코포레이티드 | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| CN102459221A (en) * | 2009-04-30 | 2012-05-16 | 住友化学株式会社 | Thiophene derivatives |
| SG186229A1 (en) | 2010-06-07 | 2013-01-30 | Novomedix Llc | Furanyl compounds and the use thereof |
| TW201323419A (en) * | 2011-10-27 | 2013-06-16 | Astellas Pharma Inc | Aminoalkyl-substituted N-thienylbenzamide derivative |
| MX366293B (en) | 2012-08-21 | 2019-07-04 | Ardelyx Inc | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders. |
| US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| KR20210117282A (en) | 2013-04-12 | 2021-09-28 | 알데릭스, 인코포레이티드 | Nhe3-binding compounds and methods for inhibiting phosphate transport |
| AU2018206479B2 (en) | 2017-01-09 | 2022-07-14 | Ardelyx, Inc. | Inhibitors of NHE-mediated antiport |
| WO2018129552A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
| JPWO2019167863A1 (en) | 2018-02-27 | 2021-03-04 | 日本曹達株式会社 | Heteroaryl sulfonamide compounds and pest control agents |
| WO2022193187A1 (en) * | 2021-03-17 | 2022-09-22 | Biofront Ltd. (Cayman) | Modulators of fpr1 and methods of using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03204875A (en) * | 1989-10-03 | 1991-09-06 | Wakamoto Pharmaceut Co Ltd | Tetrazoleacetic acid derivative and aldose reductase inhibitor comprising same derivative as active ingredient |
| KR100720844B1 (en) * | 1998-07-08 | 2007-05-25 | 사노피-아벤티스 도이칠란트 게엠베하 | Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, and pharmaceutical preparations comprising them |
-
2001
- 2001-10-05 WO PCT/US2001/031318 patent/WO2002028353A2/en active Application Filing
- 2001-10-05 AU AU2002213048A patent/AU2002213048A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002028353A3 (en) | 2002-07-11 |
| WO2002028353A2 (en) | 2002-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002213048A1 (en) | Phosphate transport inhibitors | |
| AU2001258771A1 (en) | -secretase inhibitors | |
| AU2001237041A1 (en) | Kinase inhibitors | |
| AU4882101A (en) | Mmp-12 inhibitors | |
| AU2001234088A1 (en) | TNF-alpha inhibitors | |
| AU2002211663A1 (en) | Nf-$g(k)b inhibitors | |
| IL147697A0 (en) | Phosphate transport inhibitors | |
| AU2001258784A1 (en) | Tyrosine phosphatase inhibitors | |
| AU2001259354A1 (en) | Phosphate transport inhibitors | |
| AU2001285750A1 (en) | Urokinase inhibitors | |
| AU2001236052A1 (en) | Urease inhibitors | |
| AU2001294557A1 (en) | Thrombin inhibitors | |
| AU2002211662A1 (en) | Nf-kappab inhibitors | |
| IL152587A0 (en) | Phosphate transport inhibitors | |
| AU2002222627A1 (en) | Tak1 inhibitors | |
| AU2002218760A1 (en) | Transport system | |
| AU7961300A (en) | Kainic acid neurocytotoxicity inhibitors | |
| AU3235100A (en) | Prothease inhibitors | |
| AU2001232245A1 (en) | Tnf- alpha inhibitors | |
| AU2002224550A1 (en) | Corrosion inhibitors | |
| GB0030284D0 (en) | Enzyme inhibitors | |
| AUPP885899A0 (en) | Transport aid | |
| AU1588901A (en) | Protease inhibitors | |
| AU2030999A (en) | Glycine transport inhibitors | |
| AU1474801A (en) | Protease inhibitors |